StoneX Group’s Lifestance Health LFST Stock Holding History

StoneX Group’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$132K	Buy	+10,748	New	+$127K	﹤0.01%	1455

Other funds holding LFST

Summit Partners Boston, Massachusetts $491M AUM 11.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

StoneX Group's LFST Position: Q3 2026 in Review

StoneX Group opened a new position in Lifestance Health (LFST) in Q3 2026: 10,748 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #1455 among its holdings.

133 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

StoneX Group held 10,748 shares of Lifestance Health worth $132K as of Q3 2026.
Lifestance Health was a new StoneX Group position in Q3 2026.
Lifestance Health made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1455 holding.
133 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.